Skip to content

evaluation of the effect of acupuncture in control of the symptoms in patients with restless leg syndrome

evaluation of the effect of acupuncture in control of the symptoms in patients with restless leg syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2015102724742N1
Enrollment
46
Registered
2015-11-19
Start date
2015-11-06
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

restless leg syndrome. Other specified extrapyramidal and movement disorder: Restless legs syndrome Stiff-man syndromes

Interventions

Intervention 1: intervention group: underwent treatment of 300 mg gabapentin daily concomitant of 10 session 40 HZ frequency electro Acupuncture over 30 minutes over maximum 3 session in weeks durin
Treatment - Other
Treatment - Drugs
intervention group: underwent treatment of 300 mg gabapentin daily concomitant of 10 session 40 HZ frequency electro Acupuncture over 30 minutes over maximum 3 session in weeks during 4 weeks. If af
Control group: underwent treatment of 300 mg gabapentin daily. If after 4 weeks the signs of the patients improved less than 30% according to VAS increase the dosage of gabapentin.

Sponsors

Iran University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: inclusion criteria: men and women 18 years old up to 65 years old who have restless legs with duration more than 6 month and have the four diagnostic criteria for Restless Legs Syndrome: 1- an urge to move the legs, 2- that is present at rest, 3- relieved by movement, 4- demonstrates a circadian pattern with peak symptoms occurring at night or in the evening. exclusion criteria: patients who have treatable systemic disorder such as renal failure; iron deficiency anemia; thyroid dysfunction; Patients with Pregnancy; immune deficiency; coagulation disease; cancer; diffuse skin lesions; cardiac pacemaker; infection on the areas of acupuncture also other neurologic disorder such as levodopa dependent dyskinesia; neuroleptic dependent akathisia; Tourette syndrome; attention deficit hyperactivity disorder(ADHD) and anxiety disorders.

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Severity of leg restlessness. Timepoint: in start of study, first month and second month after start of study. Method of measurement: International Restless Legs Syndrome Study Group(IRLSSG) questionnaire.;Severity of leg restlessness. Timepoint: in start of study, first month and second month after start of study. Method of measurement: Visual Analogue Scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactSamaneh Ghahramanpoori

Department of physical medicine and rehabilitation, Iran University of Medical Sciences

s.ghahramanpoori@gmail.com+98 21 8214 1229

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026